Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Starpharma's DNT to Develop Water Purification Technology Under US Defense Dept Contract

Starpharma today announced that its wholly owned subsidiary Dendritic Nanotechnologies Inc (DNT) will develop its proprietary technology to purify water following the award of a contract with the US Department of Defense's (DoD) Strategic Environmental Research and Development Program.

Starpharma's DNT to Develop Water Purification Technology Under US Defense Dept Contract

MOUNT PLEASANT, MI | Posted on August 8th, 2007

The US$1.3m DoD contract was awarded to DNT and the Central Michigan University Research Corporation to develop water remediation technology using DNT's Priostar(TM) dendrimer-based nanotechnology.

The dendrimer is to act as a sponge to soak up toxic chemicals from ground-water, leaving the water purer and useable. The ability of a dendrimer to pack a large functional surface area into a small particle makes it an appropriate choice for the application.

Successful completion of this project, which was sponsored by U.S. Senator Carl Levin and Congressman David Camp, will provide DoD with a new generation cost effective, environmentally acceptable water remediation system. Starpharma retains commercialisation rights to technology developed under the program.

Starpharma CEO Jackie Fairley commented: "Uncontaminated water is already in short supply in many regions throughout the world and increased water stress resulting from climate change is expected to make things worse. Whilst this is a non-core area for Starpharma it addresses an important global issue and is a commercially relevant application of dendrimers which may yield royalty income in the future."


About Starpharma
Starpharma Holdings Limited is a world leader in the development of dendrimer nanotechnology for pharmaceutical, life-science and other applications. SPL is principally composed of two operating companies, Starpharma Pty Ltd in Melbourne, Australia and Dendritic Nanotechnologies, Inc in Michigan, USA. Products based on SPL's dendrimer technology are already on the market in the form of diagnostic elements and laboratory reagents.

The Company's lead pharmaceutical development product is VivaGel(TM) (SPL7013 Gel), a vaginal microbicide designed to prevent the transmission of STIs, including HIV and genital herpes.

In the pharmaceutical field Starpharma has additional specific programs in the areas of Drug Delivery and ADME Engineering(TM) (using dendrimers to control where and when drugs go when introduced to the body), Polyvalency (using the fact that dendrimers can activate multiple receptors simultaneously) and Targeted Diagnostics (using dendrimers as a scaffold to which both location-signalling and targeting groups are added to allow location of specific cell type, such as cancer cells).

For more information, please click here

Rebecca Piercy
Buchan Consulting
Tel: +61 2 9237 2800
Mob: +61 422916422


Dr Jackie Fairley
Chief Executive Officer
Starpharma Holdings Ltd
+61 3 8532 2704

Dr Robert Berry
Tel: 989.774.1799

Ben Rogers
Company Secretary
Starpharma Holdings Ltd
+61 3 8532 2702

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Metamaterial device allows chameleon-like behavior in the infrared October 28th, 2016

A Tiny Machine: UCSB electrical and computer engineers design an infinitesimal computing device October 28th, 2016

The molecular mechanism that blocks membrane receptors has been identified: The work in which the Ikerbasque researcher of the Biofisika Institute Xabier Contreras has participated has been published in the journal Cell October 27th, 2016

Imaging where cancer drugs go in the body could improve treatment October 26th, 2016


Unusual quantum liquid on crystal surface could inspire future electronics October 22nd, 2016

New perovskite solar cell design could outperform existing commercial technologies: Stanford, Oxford team creates high-efficiency tandem cells October 21st, 2016

Study explains strength gap between graphene, carbon fiber: Rice University researchers simulate defects in popular fiber, suggest ways to improve it October 19th, 2016

Study finds surface texture of gallium nitride affects cell behavior October 17th, 2016


How nanoscience will improve our health and lives in the coming years: Targeted medicine deliveries and increased energy efficiency are just two of many ways October 26th, 2016

Water vapor sets some oxides aflutter: Newly discovered phenomenon could affect materials in batteries and water-splitting devices October 3rd, 2016

Oxford Instruments systems now facilitate water purification technology September 27th, 2016

Atomic scale pipes available on demand and by design September 9th, 2016

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project